Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience

Ovarian cancer (OC) ranks fifth in mortality among females cancer patients. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) have radically changed the treatment of OC. The aim of this study was to evaluate overall survival (OS) and disease-free survival (DFS) in ou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of B.U. ON. 2016-09, Vol.21 (5), p.1176-1183
Hauptverfasser:	Kocic, Milan, Nikolic, Srdjan, Zegarac, Milan, Djurisic, Igor, Soldatovic, Ivan, Milenkovic, Petar, Kocic, Jovana
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Chemotherapy, Adjuvant Cytoreduction Surgical Procedures - adverse effects Cytoreduction Surgical Procedures - mortality Databases, Factual Disease-Free Survival Female Humans Hypothermia, Induced - adverse effects Hypothermia, Induced - mortality Kaplan-Meier Estimate Middle Aged Ovarian Neoplasms - mortality Ovarian Neoplasms - pathology Ovarian Neoplasms - therapy Peritoneal Neoplasms - mortality Peritoneal Neoplasms - secondary Peritoneal Neoplasms - therapy Proportional Hazards Models Risk Factors Serbia Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!